ES8403865A1 - Procedimiento para la preparacion de derivados de carbaciclina - Google Patents
Procedimiento para la preparacion de derivados de carbaciclinaInfo
- Publication number
- ES8403865A1 ES8403865A1 ES524058A ES524058A ES8403865A1 ES 8403865 A1 ES8403865 A1 ES 8403865A1 ES 524058 A ES524058 A ES 524058A ES 524058 A ES524058 A ES 524058A ES 8403865 A1 ES8403865 A1 ES 8403865A1
- Authority
- ES
- Spain
- Prior art keywords
- group
- denotes
- radical
- atoms
- hydrogen atom
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000003814 drug Substances 0.000 title abstract 2
- 229940079593 drug Drugs 0.000 title 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 6
- 125000000217 alkyl group Chemical group 0.000 abstract 4
- 125000004432 carbon atom Chemical group C* 0.000 abstract 4
- 125000002947 alkylene group Chemical group 0.000 abstract 2
- 125000003118 aryl group Chemical group 0.000 abstract 2
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 2
- 125000001153 fluoro group Chemical group F* 0.000 abstract 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 2
- 101100294106 Caenorhabditis elegans nhr-3 gene Proteins 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 229910052731 fluorine Inorganic materials 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- -1 hydroxymethylene group Chemical class 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 229920006395 saturated elastomer Polymers 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/72—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 spiro-condensed with carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
- C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
- C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
- C07C405/005—Analogues or derivatives having the five membered ring replaced by other rings
- C07C405/0075—Analogues or derivatives having the five membered ring replaced by other rings having the side-chains or their analogues or derivatives attached to a condensed ring system
- C07C405/0083—Analogues or derivatives having the five membered ring replaced by other rings having the side-chains or their analogues or derivatives attached to a condensed ring system which is only ortho or peri condensed, e.g. carbacyclins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
- C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D317/16—Radicals substituted by halogen atoms or nitro radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Pulmonology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Inks, Pencil-Leads, Or Crayons (AREA)
- Drawers Of Furniture (AREA)
- Ink Jet Recording Methods And Recording Media Thereof (AREA)
- Pyrane Compounds (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
Abstract
PROCEDIMIENTO PARA LA OBTENCION DE DERIVADOS DE CARBACICLINA Y DE SUS SALES CON BASES FISIOLOGICAMENTE COMPATIBLES, DE FORMULA (I), EN LA QUE R5 ES HIDROXI, LIBRE O MODIFICADO; R1, R4, A, W, D Y E PUEDEN SER VARIOS TIPOS DE RADICALES; Y N VALE 2-5.CONSISTE EN LA REACCION DE ESTERIFICACION, EN PRESENCIA DE UNA BASE, DE UN COMPUESTO DE FORMULA (II), CON UN HALOGENOCETAL, DE FORMULA (III), EN LAS QUE HAL ES CLORO, BROMO O YODO, R8 Y R9 SON ALCOHILO C1-10, O JUNTOS CONSTITUYEN UN GRUPO FORMADOR DE ANILLO, Y LOS DEMAS SIMBOLOS TIENEN EL MISMO SIGNIFICADO QUE EN LA FORMULA(I); SEGUIDA DEL DESDOBLAMIENTO DEL CETAL CON UN ACIDO.ESTOS COMPUESTOS TIENEN APLICACIONES FARMACOLOGICAS POR SU EFECTO HIPOTENSOR Y BRONCODILATATORIO Y POR SU ACCION VASODILATADORA Y DE SECRECION DE ACIDOS GASTRICOS.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19823226550 DE3226550A1 (de) | 1982-07-13 | 1982-07-13 | Neue carbacycline, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ES8403865A1 true ES8403865A1 (es) | 1984-04-16 |
| ES524058A0 ES524058A0 (es) | 1984-04-16 |
Family
ID=6168531
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES524058A Granted ES524058A0 (es) | 1982-07-13 | 1983-07-12 | Procedimiento para la preparacion de derivados de carbaciclina |
Country Status (19)
| Country | Link |
|---|---|
| EP (1) | EP0099538B1 (es) |
| JP (1) | JPS5921636A (es) |
| AT (1) | ATE67182T1 (es) |
| AU (1) | AU571841B2 (es) |
| CA (1) | CA1248525A (es) |
| CS (1) | CS235329B2 (es) |
| DD (1) | DD210027B3 (es) |
| DE (2) | DE3226550A1 (es) |
| DK (1) | DK163579C (es) |
| ES (1) | ES524058A0 (es) |
| FI (1) | FI77645C (es) |
| GR (1) | GR78873B (es) |
| HU (1) | HU191057B (es) |
| IE (1) | IE57233B1 (es) |
| IL (1) | IL69199A (es) |
| NZ (1) | NZ204875A (es) |
| PH (1) | PH25119A (es) |
| SU (1) | SU1316555A3 (es) |
| ZA (1) | ZA835109B (es) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3225288A1 (de) * | 1982-07-02 | 1984-01-19 | Schering AG, 1000 Berlin und 4709 Bergkamen | Neue carbacycline, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel |
| DE3225287A1 (de) * | 1982-07-02 | 1984-01-05 | Schering AG, 1000 Berlin und 4709 Bergkamen | Neue carbacyclinamide, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel |
| JPS59141536A (ja) * | 1983-02-01 | 1984-08-14 | Sumitomo Chem Co Ltd | 新規ビシクロオクタン誘導体 |
| DE3405181A1 (de) * | 1984-02-10 | 1985-08-22 | Schering AG, 1000 Berlin und 4709 Bergkamen | Neue carbacycline, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel |
| US4971987A (en) * | 1984-07-27 | 1990-11-20 | Schering Aktiengesellschaft | New carbacycline, process for their production and their use as a drug |
| DE3933523A1 (de) * | 1989-10-05 | 1991-04-11 | Schering Ag | Antimetastatisch wirkende mittel |
| EP0431571A3 (en) * | 1989-12-05 | 1992-01-02 | Sagami Chemical Research Center | Cis-bicyclo(4.3.0)non-2-ene derivatives |
| DE4104607A1 (de) * | 1991-02-12 | 1992-08-13 | Schering Ag | Prostacyclin- und carbacyclinderivate als mittel zur behandlung von fiebrigen erkrankungen |
| CA2382759A1 (en) | 1999-08-05 | 2001-02-15 | Teijin Limited | Agent for the remedy of neural damage having a nitrogen-containing compound as the active ingredient |
| US8183286B2 (en) | 2006-11-16 | 2012-05-22 | Gemmus Pharma Inc. | EP2 and EP4 agonists as agents for the treatment of influenza a viral infection |
| NZ599128A (en) | 2009-10-14 | 2014-02-28 | Gemmus Pharma Inc | Combination therapy treatment for viral infections |
| JP6694385B2 (ja) | 2013-08-09 | 2020-05-13 | アーデリクス，インコーポレーテッド | リン酸塩輸送阻害のための化合物及び方法 |
| JP2022533251A (ja) | 2019-05-21 | 2022-07-21 | アルデリックス， インコーポレイテッド | 患者において血清リン酸塩を低下させるための組み合わせ |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2040928B (en) * | 1978-01-26 | 1982-12-08 | Erba Farmitalia | Bicycloalkane derivatives useful as intermediates in preparing pg1 isosteres |
| US4705806A (en) * | 1978-02-13 | 1987-11-10 | Morton Jr Douglas R | Prostacyclin analogs |
| DE3048906A1 (de) * | 1980-12-19 | 1982-07-15 | Schering Ag, 1000 Berlin Und 4619 Bergkamen | Neue carbacycline, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel |
| IE54303B1 (en) * | 1981-08-19 | 1989-08-16 | Merrell Dow France | Fluorinated diaminoalkene derivatives |
| GR77976B (es) * | 1982-03-12 | 1984-09-25 | Schering Ag | |
| DE3225287A1 (de) * | 1982-07-02 | 1984-01-05 | Schering AG, 1000 Berlin und 4709 Bergkamen | Neue carbacyclinamide, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel |
-
1982
- 1982-07-13 DE DE19823226550 patent/DE3226550A1/de not_active Ceased
-
1983
- 1983-07-06 DD DD83252808A patent/DD210027B3/de not_active IP Right Cessation
- 1983-07-11 EP EP83106792A patent/EP0099538B1/de not_active Expired - Lifetime
- 1983-07-11 AT AT83106792T patent/ATE67182T1/de not_active IP Right Cessation
- 1983-07-11 AU AU16718/83A patent/AU571841B2/en not_active Ceased
- 1983-07-11 DE DE8383106792T patent/DE3382408D1/de not_active Expired - Lifetime
- 1983-07-11 GR GR71905A patent/GR78873B/el unknown
- 1983-07-12 IL IL69199A patent/IL69199A/xx not_active IP Right Cessation
- 1983-07-12 SU SU833615553A patent/SU1316555A3/ru active
- 1983-07-12 HU HU832481A patent/HU191057B/hu not_active IP Right Cessation
- 1983-07-12 NZ NZ204875A patent/NZ204875A/en unknown
- 1983-07-12 ES ES524058A patent/ES524058A0/es active Granted
- 1983-07-12 DK DK321283A patent/DK163579C/da not_active IP Right Cessation
- 1983-07-12 CA CA000432232A patent/CA1248525A/en not_active Expired
- 1983-07-12 JP JP58125615A patent/JPS5921636A/ja active Granted
- 1983-07-12 PH PH29208A patent/PH25119A/en unknown
- 1983-07-13 CS CS835301A patent/CS235329B2/cs unknown
- 1983-07-13 IE IE1630/83A patent/IE57233B1/en not_active IP Right Cessation
- 1983-07-13 FI FI832557A patent/FI77645C/fi not_active IP Right Cessation
- 1983-07-13 ZA ZA835109A patent/ZA835109B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP0099538B1 (de) | 1991-09-11 |
| ATE67182T1 (de) | 1991-09-15 |
| IE831630L (en) | 1984-01-13 |
| CS235329B2 (en) | 1985-05-15 |
| FI77645B (fi) | 1988-12-30 |
| HU191057B (en) | 1986-12-28 |
| EP0099538A1 (de) | 1984-02-01 |
| JPS5921636A (ja) | 1984-02-03 |
| DK321283D0 (da) | 1983-07-12 |
| AU1671883A (en) | 1984-01-19 |
| DE3382408D1 (de) | 1991-10-17 |
| FI832557A (fi) | 1984-01-14 |
| JPH0324457B2 (es) | 1991-04-03 |
| DK321283A (da) | 1984-01-14 |
| ZA835109B (en) | 1984-08-29 |
| CA1248525A (en) | 1989-01-10 |
| IL69199A0 (en) | 1983-11-30 |
| GR78873B (es) | 1984-10-02 |
| PH25119A (en) | 1991-02-19 |
| SU1316555A3 (ru) | 1987-06-07 |
| FI77645C (fi) | 1989-04-10 |
| DD210027B3 (de) | 1990-07-18 |
| DK163579C (da) | 1992-08-03 |
| NZ204875A (en) | 1986-11-12 |
| DD210027A5 (de) | 1984-05-30 |
| AU571841B2 (en) | 1988-04-28 |
| DK163579B (da) | 1992-03-16 |
| IL69199A (en) | 1987-08-31 |
| DE3226550A1 (de) | 1984-01-19 |
| IE57233B1 (en) | 1992-06-17 |
| ES524058A0 (es) | 1984-04-16 |
| FI832557A0 (fi) | 1983-07-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES8403865A1 (es) | Procedimiento para la preparacion de derivados de carbaciclina | |
| IL64577A0 (en) | Carbaprostacyclin derivatives,process for their preparation and pharmaceutical preparations containing them | |
| DE3268528D1 (en) | Derivatives of 9-fluoroprostaglandin, process for their preparation and their use as medicaments | |
| GB1205957A (en) | Pharmaceutical compositions comprising 1-pnenoxy-2-aminopropanes | |
| ES8405355A1 (es) | Procedimiento para la preparacion de derivados de 5-fluorocarbaciclinas | |
| ES474367A1 (es) | Procedimiento de preparacion de nuevos derivados del benzo- (d)tiazol. | |
| EP0069049A3 (en) | Delta-8,9-prostaglandin derivatives, process for their preparation and their use as medicaments | |
| JPS52100470A (en) | Synthesis of hydantoin derivatives | |
| JPS5253897A (en) | Process for preparing, n6-etheno-2-subtituted-thio-adenosine-2', 5'pho sphates | |
| ATE92461T1 (de) | Gegen die zerebrale insuffizienz wirksame verbindungen. | |
| DK101085A (da) | Carbacycliner, fremgangsmaade til deres fremstilling og deres anvendelse som laegemidler | |
| ES8307838A1 (es) | Procedimiento para la preparacion de 3-deshidro-cardenolido-tridigitoxosido-oximas. | |
| DE3275083D1 (en) | Cycloaliphatic alcohols |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD1A | Patent lapsed |
Effective date: 19980924 |